Fundraising FoxDeepWork Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Cyrano Therateuticscyranotherapeutics.cominJan 2024 · $9M✓ verified
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste.
BiotechDigital HealthHealthtechMedical DevicesDelray Beach, US
Rick Geoffrion(Founder, President and CEO & Board Member)inRichard Geoffrion(Executive Officer, Director)Robert Henkin(Director)
BoardGerry Brunk(Director)inTakahide Koda(Director)
Co-investorsLumira VenturesRemiges Ventures, Inc.Florida Opportunity Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.